Previous 10 | Next 10 |
Some Penny Stocks To Watch Ahead Of Tuesday’s Open This week is a shortened week thanks to Martin Luther King, Jr. Day on January 20th. In observation of the holiday, U.S. markets will be closed. However, trading will resume once again on the 21st. Given that fact, it not only gives tra...
These Penny Stocks Are Up Big In Q4 2019 Investing in penny stocks is not that different from investing in other classes of stocks. The same process to sell or buy penny stocks is the same you would for blue-chip stocks . However, the big differences come when you consider risk. Obviously...
We argued more than a year ago that IsoRay ( ISR ) had exciting prospects, and this indeed turned out to be the case. From mid 2018 when we wrote our previous article things have moved up on multiple parameters with strong revenue growth and operational improvements: Data by YCharts So ...
These Penny Stocks Trade For Less Than A Cup Of Coffee But Are They Worth Your Time? One of the main attractions of penny stocks is the fact that they are cheap. But they also have the potential of generating enormous returns if the company grows. Penny stocks generally trade below $5, but...
IsoRay, Inc. (ISR) Q1 2020 Earnings Conference Call November 12, 2019 04:30 PM ET Company Participants Mark Levin - IR Lori Woods - CEO Jonathan Hunt - Co-Principal Financial Officer Conference Call Participants Ed Woo - Ascendiant Capital Arthur He - H.C. Wainwright P...
IsoRay (NYSEMKT: ISR ): Q1 GAAP EPS of -$0.01 beats by $0.01 . Revenue of $2.32M (+48.7% Y/Y) beats by $0.37M . Shares -0.8% . Press Release More news on: IsoRay, Inc., Earnings news and commentary, Healthcare stocks news, ,
Record Revenue and Gross Profit Revenue Increased 48% Year-Over-Year RICHLAND, Wash., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, tod...
RICHLAND, Wash., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss its financi...
RICHLAND, Wash., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR) announced today that it will demonstrate its latest products at the American Brachytherapy Society’s (ABS) annual prostate brachytherapy workshop. The workshop is scheduled to tak...
IsoRay, Inc. (ISR) Q4 2019 Results Earnings Conference Call September 24, 2019, 04:30 PM ET Company Participants Mark Levin - IR Lori Woods - CEO Jonathan Hunt - Co-Principal Financial Officer Conference Call Participants Jason Kolbert - Dawson James Ed Woo - Ascendiant ...
News, Short Squeeze, Breakout and More Instantly...
IsoRay Inc. Company Name:
ISR Stock Symbol:
NYSE Market:
RICHLAND, Wash. and CORALVILLE, Iowa, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (formerly known as Isoray, Inc.) (NYSE AMERICAN: ISR), a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents and an innovator in seed b...
C omp any’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies New corporate tagline and website introduced N ew ticker symbol to be NYSE American: CATX RICHLAND,...
The combination delivers the promise of bringing powerful new perspectives to the rapidly emerging field of Alpha-Particle radiopharmaceuticals Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced the successful complet...